Last 12 months
Inside the activity.
0 purchase rows · 457 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 47 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 41 |
| Feb 2026 | 0 | 21 |
| Mar 2026 | 0 | 54 |
| Apr 2026 | 0 | 29 |
| May 2026 | 0 | 33 |
| Jun 2026 | 0 | 68 |
| Jul 2026 | 0 | 47 |
| Aug 2026 | 0 | 33 |
| Sep 2026 | 0 | 59 |
| Oct 2026 | 0 | 4 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 687 | $0.00 Strike: $45.88 | $0.00 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 18 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 687 shares Expires 2033-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 607 | $0.00 Strike: $51.40 | $0.00 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 17 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 607 shares Expires 2033-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 793 | $0.00 Strike: $41.82 | $0.00 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 16 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 793 shares Expires 2033-01-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 851 | $0.00 Strike: $41.51 | $0.00 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 15 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 851 shares Expires 2032-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 884 | $0.00 Strike: $40.48 | $0.00 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 14 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 884 shares Expires 2032-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 14,136 | $0.00 Strike: $41.19 | $0.00 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 13 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,136 shares Expires 2032-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 735 | $0.00 Strike: $42.86 | $0.00 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 12 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 735 shares Expires 2032-04-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 424 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · derivative · entry 11 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 424 shares Expires 2032-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionCommon Stock | 807 | $38.26 | $30,875.82 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 9 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionCommon Stock | 687 | $45.88 | $31,519.56 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 8 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionCommon Stock | 607 | $51.40 | $31,199.80 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 7 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionCommon Stock | 793 | $41.82 | $33,163.26 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 6 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionCommon Stock | 851 | $41.51 | $35,325.01 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 5 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionCommon Stock | 884 | $40.48 | $35,784.32 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 4 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionCommon Stock | 14,136 | $41.19 | $582,261.84 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 3 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionCommon Stock | 735 | $42.86 | $31,502.10 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 2 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
Exercise / conversionCommon Stock | 424 | $67.37 | $28,564.88 |
DisclosureSEC source: 0001415889-24-008184 · form4-03152024_090305.xml · nonDerivative · entry 1 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 30, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 20,070 | $89.60 | $1,798,370.34 |
DisclosureSEC source: 0001415889-24-009473 · form4-03292024_090304.xml · nonDerivative · entry 3 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Indirect · By Chapman Family Trust Disclosed balance after: 0 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.4050 to $89.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The Reporting Person is a trustee of the Chapman Family Trust and has voting and dispositive power with respect to the reported shares. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| March 15, 2024 Filed Mar 30, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 20,575 | $88.97 | $1,830,574.21 |
DisclosureSEC source: 0001415889-24-009473 · form4-03292024_090304.xml · nonDerivative · entry 2 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Indirect · By Chapman Family Trust Disclosed balance after: 20,070 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.4050 to $89.39 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The Reporting Person is a trustee of the Chapman Family Trust and has voting and dispositive power with respect to the reported shares. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| March 15, 2024 Filed Mar 30, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 10,265 | $87.98 | $903,120.86 |
DisclosureSEC source: 0001415889-24-009473 · form4-03292024_090304.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Indirect · By Chapman Family Trust Disclosed balance after: 40,645 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.4050 to $88.40 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 50,910 shares previously reported as owned indirectly by the Rosewood Trust. F4 · ownership.nature: The Reporting Person is a trustee of the Chapman Family Trust and has voting and dispositive power with respect to the reported shares. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| March 07, 2024 Filed Mar 9, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
GiftCommon Stock | 55,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007459 · form4-03082024_080301.xml · nonDerivative · entry 3 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Indirect · By Caraluna 2 Trust Disclosed balance after: 70,082 F2 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| March 07, 2024 Filed Mar 9, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
GiftCommon Stock | 55,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007459 · form4-03082024_080301.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Indirect · By Caraluna 1 Trust Disclosed balance after: 70,082 F2 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| March 07, 2024 Filed Mar 9, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
GiftCommon Stock | 110,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007459 · form4-03082024_080301.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,731 F1 · shares: The transaction represents a gift by the Reporting Person. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 02:40 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 1,816 | $89.13 | $161,856.81 |
DisclosureSEC source: 0001415889-24-007247 · form4-03072024_090320.xml · nonDerivative · entry 3 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 458,585 F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.03 to $89.19 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 02:40 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 3,184 | $88.45 | $281,635.31 |
DisclosureSEC source: 0001415889-24-007247 · form4-03072024_090320.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 460,401 F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.99 to $88.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
SaleCommon Stock | 1,823 | $88.37 | $161,089.40 |
DisclosureSEC source: 0001415889-24-007242 · form4-03072024_090304.xml · nonDerivative · entry 3 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,663 F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
SaleCommon Stock | 15 | $87.37 | $1,310.48 |
DisclosureSEC source: 0001415889-24-007242 · form4-03072024_090304.xml · nonDerivative · entry 2 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,486 F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
SaleCommon Stock | 2,227 | $88.37 | $196,788.86 |
DisclosureSEC source: 0001415889-24-007243 · form4-03072024_090309.xml · nonDerivative · entry 3 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,267 F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
SaleCommon Stock | 18 | $87.33 | $1,571.86 |
DisclosureSEC source: 0001415889-24-007243 · form4-03072024_090309.xml · nonDerivative · entry 2 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,494 F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.31 to $87.3415 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 9,326 | $88.37 | $824,091.99 |
DisclosureSEC source: 0001415889-24-007245 · form4-03072024_090316.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,957 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units and in compliance with Rule 10b5-1. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 2,826 | $88.37 | $249,719.49 |
DisclosureSEC source: 0001415889-24-007244 · form4-03072024_090314.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,646 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units and in compliance with Rule 10b5-1. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 1,028 | $88.37 | $90,839.22 |
DisclosureSEC source: 0001415889-24-007247 · form4-03072024_090320.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 463,585 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units and in compliance with Rule 10b5-1. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 2,160 | $88.37 | $190,868.40 |
DisclosureSEC source: 0001415889-24-007246 · form4-03072024_090318.xml · nonDerivative · entry 1 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,218 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units and in compliance with Rule 10b5-1. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 5,492 | $89.40 | $491,004.02 |
DisclosureSEC source: 0001415889-24-007241 · form4-03072024_090301.xml · nonDerivative · entry 6 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Indirect · By RMDM Trust Disclosed balance after: 860,036 F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2023. F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.15 to $89.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The RMDM Trust is an irrevocable spendthrift trust for the benefit of the Reporting Person and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the RMDM Trust, the Reporting Person has no enforceable rights to distributions. The RMDM Trust is a fully discretionary trust and the distribution decisions for the RMDM Trust are vested in a committee. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 13,743 | $88.64 | $1,218,237.24 |
DisclosureSEC source: 0001415889-24-007241 · form4-03072024_090301.xml · nonDerivative · entry 5 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Indirect · By RMDM Trust Disclosed balance after: 865,528 F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2023. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.15 to $89.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The RMDM Trust is an irrevocable spendthrift trust for the benefit of the Reporting Person and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the RMDM Trust, the Reporting Person has no enforceable rights to distributions. The RMDM Trust is a fully discretionary trust and the distribution decisions for the RMDM Trust are vested in a committee. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 96,977 | $87.49 | $8,484,963.82 |
DisclosureSEC source: 0001415889-24-007241 · form4-03072024_090301.xml · nonDerivative · entry 4 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Indirect · By RMDM Trust Disclosed balance after: 879,271 F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2023. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.15 to $88.10 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The RMDM Trust is an irrevocable spendthrift trust for the benefit of the Reporting Person and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the RMDM Trust, the Reporting Person has no enforceable rights to distributions. The RMDM Trust is a fully discretionary trust and the distribution decisions for the RMDM Trust are vested in a committee. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 73,788 | $86.88 | $6,410,863.77 |
DisclosureSEC source: 0001415889-24-007241 · form4-03072024_090301.xml · nonDerivative · entry 3 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Indirect · By RMDM Trust Disclosed balance after: 976,248 F2 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.15 to $87.14 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The RMDM Trust is an irrevocable spendthrift trust for the benefit of the Reporting Person and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the RMDM Trust, the Reporting Person has no enforceable rights to distributions. The RMDM Trust is a fully discretionary trust and the distribution decisions for the RMDM Trust are vested in a committee. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 1,004 | $88.37 | $88,718.46 |
DisclosureSEC source: 0001415889-24-007241 · form4-03072024_090301.xml · nonDerivative · entry 2 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,075,648 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units and in compliance with Rule 10b5-1. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:40 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 8 | $87.25 | $698.00 |
DisclosureSEC source: 0001415889-24-007241 · form4-03072024_090301.xml · nonDerivative · entry 1 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,076,652 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units and in compliance with Rule 10b5-1. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 01:45 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
GrantCommon Stock | 2,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-006193 · form4-03012024_080301.xml · nonDerivative · entry 1 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,894 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 01:45 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
GrantCommon Stock | 2,329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-006194 · form4-03012024_080304.xml · nonDerivative · entry 1 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,306 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 01:45 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
GrantCommon Stock | 9,326 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-006196 · form4-03012024_080311.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,283 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 01:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 2,826 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-006195 · form4-03012024_080309.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,472 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 01:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
GrantCommon Stock | 1,028 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-006199 · form4-03012024_080324.xml · nonDerivative · entry 7 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 464,613 F10 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance. F11 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 01:45 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
GrantCommon Stock | 4,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-006198 · form4-03012024_080319.xml · nonDerivative · entry 1 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,076,660 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 01:45 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
GrantCommon Stock | 2,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-006197 · form4-03012024_080313.xml · nonDerivative · entry 1 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,378 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 02:15 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,526 | $0.00 Strike: $9.29 | $0.00 |
DisclosureSEC source: 0001415889-24-006005 · form4-02292024_090201.xml · derivative · entry 11 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,526 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 02:15 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 14,426 | $89.72 | $1,294,351.21 |
DisclosureSEC source: 0001415889-24-006005 · form4-02292024_090201.xml · nonDerivative · entry 8 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 204,218 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.53 to $89.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 02:15 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 3,400 | $87.87 | $298,765.14 |
DisclosureSEC source: 0001415889-24-006005 · form4-02292024_090201.xml · nonDerivative · entry 7 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 218,644 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.80 to $88.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 02:15 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 2,600 | $86.67 | $225,344.08 |
DisclosureSEC source: 0001415889-24-006005 · form4-02292024_090201.xml · nonDerivative · entry 6 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,044 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.43 to $87.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.